# A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas

> **NCT05566743** · PHASE2 · UNKNOWN · sponsor: **Menoufia University** · enrollment: 40 (estimated)

## Conditions studied

- Cancer of Pancreas

## Interventions

- **DRUG:** Capecitabine
- **OTHER:** follow up

## Key facts

- **NCT ID:** NCT05566743
- **Lead sponsor:** Menoufia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-11
- **Primary completion:** 2023-09-11
- **Final completion:** 2024-09-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05566743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05566743, "A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05566743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*